[EYES] Second Sight Medical Products, Inc.

Overview

Type of security: Stock

Sector:

Industry:

Market Capitalization: 145.96 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2.13 Change: 0.08 (3.9%)
Ext. hours: Change: 0 (0%)

chart EYES

Refresh chart

Strongest Trends Summary For EYES

EYES is in the medium-term down -49% below S&P in 1 year. In the long-term down -57% below S&P in 1 year and down -97% below S&P in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Second Sight Medical Products, Inc., a medical device company, develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients. The company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. It has operations in North America, Europe, and the Middle East. The company was formerly known as Second Sight LLC. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, California.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding36.04 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 178.23% Sales Growth - Q/Q11.84% P/E
P/E To EPS Growth P/S32.87 P/BV4.79 Price/Cash Per Share4.91
Price/Free Cash Flow-8.27 ROA-85.46% ROE-110.7% ROI
Current Ratio4.27 Quick Ratio3.56 Long Term Debt/Equity Debt Ratio0.3
Gross Margin7.05% Operating Margin-489.6% Net Profit Margin-759.41% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities290 K Cash From Investing Activities4.83 M Cash From Operating Activities-5.03 M Gross Profit400 K
Net Profit-4.96 M Operating Profit-4.96 M Total Assets39.46 M Total Current Assets38.4 M
Total Current Liabilities9 M Total Debt Total Liabilities9 M Total Revenue1.7 M
Technical Data
High 52 week2.23 Low 52 week0.69 Last close0.69 Last change-11.96%
RSI37.84 Average true range0.05 Beta0.66 Volume438.22 K
Simple moving average 20 days-8.41% Simple moving average 50 days-16.57% Simple moving average 200 days-52.29%
Performance Data
Performance Week-4.72% Performance Month-16.54% Performance Quart-41.3% Performance Half-57.24%
Performance Year-55.6% Performance Year-to-date-21.77% Volatility daily3.77% Volatility weekly8.43%
Volatility monthly17.28% Volatility yearly59.86% Relative Volume704.36% Average Volume516.72 K
New High New Low

News

2019-05-16 17:00:00 | Second Sight to Present at 20th Annual B. Riley FBR Investor Conference

2019-05-15 22:39:23 | Edited Transcript of EYES earnings conference call or presentation 15-May-19 8:30pm GMT

2019-05-15 17:25:09 | Second Sight Medical Products EYES Reports Q1 Loss, Misses Revenue Estimates

2019-05-15 16:15:40 | Second Sight Medical Products: 1Q Earnings Snapshot

2019-05-15 16:05:00 | Second Sight Reports First Quarter 2019 Financial Results

2019-05-15 16:01:00 | Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System

2019-05-08 08:00:00 | Second Sight to Discuss First Quarter 2019 Financial Results on May 15, 2019 Conference Call

2019-05-02 10:32:02 | Second Sight Medical Products EYES May Report Negative Earnings: Know the Trend Ahead of Q1 Release

2019-04-17 09:13:22 | Imagine Owning Second Sight Medical Products NASDAQ:EYES And Trying To Stomach The 80% Share Price Drop

2019-04-11 08:00:00 | Second Sight Medical Products, Inc. Presents Positive Interim Results at the Fifth Annual BRAIN Initiative® Investigators Meeting

2019-04-04 10:49:02 | Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic and vTv

2019-04-03 07:57:11 | Get Over Bargain Hunting: Tap 5 Stocks With Rising P/E

2019-03-19 12:26:04 | Zacks.com featured highlights include: Catabasis, Ligand, Key, Carbonite and Second Sight

2019-03-18 09:02:01 | Rising P/E an Overlooked Criterion: 5 Top Stocks

2019-03-13 23:40:11 | Edited Transcript of EYES earnings conference call or presentation 13-Mar-19 8:30pm GMT

2019-03-13 16:34:13 | Second Sight Medical Products: 4Q Earnings Snapshot

2019-03-13 16:05:00 | Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results

2019-03-12 08:46:33 | Have Insiders Been Buying Second Sight Medical Products, Inc. NASDAQ:EYES Shares This Year?

2019-03-06 08:00:00 | Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call

2019-02-21 18:06:00 | Second Sight Medical Products, Inc. Announces Completion of Rights Offering

2019-01-22 07:35:00 | Recent Analysis Shows Abercrombie & Fitch, DaVita, W.W. Grainger, Ingredion, FirstEnergy, and Second Sight Medical Products Market Influences — Renewed Outlook, Key Drivers of Growth

2019-01-07 08:05:00 | Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants EYESW Expiration Date

2019-01-07 08:00:00 | Second Sight Reports Fourth Quarter 2018 Business Update

2018-12-20 08:00:00 | Second Sight to Present at Digital Medicine and Medtech Showcase 2019

2018-12-14 08:00:00 | Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

2018-12-04 06:18:11 | Second Sight Medical Products Sees Hammer Chart Pattern: Time to Buy?

2018-11-27 16:30:00 | Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th

2018-11-12 08:15:00 | Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-11-08 05:21:09 | Edited Transcript of EYES earnings conference call or presentation 7-Nov-18 9:30pm GMT

2018-11-07 19:10:12 | Second Sight Medical Products EYES Reports Q3 Loss, Lags Revenue Estimates

2018-11-07 18:06:22 | Second Sight Medical Products: 3Q Earnings Snapshot

2018-11-07 16:01:00 | Second Sight Reports Third Quarter 2018 Financial Results

2018-11-06 16:01:00 | Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System

2018-10-30 08:00:00 | Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call

2018-10-22 09:00:00 | Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

2018-10-18 08:30:00 | New Research Coverage Highlights QuinStreet, Senseonics, Ring Energy, Blue Apron, Second Sight Medical Products, and Real Goods Solar — Consolidated Revenues, Company Growth, and Expectations for 2018

2018-09-18 08:00:00 | Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development

2018-09-04 08:00:00 | Second Sight Appoints Pat Ryan Chief Operating Officer

2018-08-27 07:40:00 | Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products — Research Highlights Growth, Revenue, and Consolidated Results

2018-08-22 08:00:00 | Second Sight to Present at Investor Conferences in September

2018-08-16 08:26:12 | Second Sight Medical Products EYES: Moving Average Crossover Alert

2018-08-16 08:00:00 | Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

2018-08-16 03:35:22 | Edited Transcript of EYES earnings conference call or presentation 7-Aug-18 8:30pm GMT

2018-08-07 16:53:40 | Second Sight Medical Products: 2Q Earnings Snapshot

2018-08-07 16:05:00 | Second Sight Reports Second Quarter 2018 Financial Results

2018-08-07 14:30:00 | Second Sight Medical Products, Inc. to Host Earnings Call

2018-07-31 08:00:00 | Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call

2018-06-27 10:53:56 | Second Sight Medical Products Inc’s NASDAQ:EYES Shift From Loss To Profit

2018-06-21 08:25:00 | Analysis: Positioning to Benefit within Second Sight Medical Products, ICF International, Morningstar, Spark Therapeutics, Natera, and Kadmon — Research Highlights Growth, Revenue, and Consolidated Results

2018-05-23 07:15:00 | Complimentary Technical Snapshots on Prestige Brands and Three More Medical Equipment Stocks